Advertisement

Topics

Positive Phase III results for Lilly’s acute migraine drug candidate

12:30 EDT 4 Aug 2017 | thePharmaLetter

In a second Phase III study, Eli Lilly’s lasmiditan, an investigational, oral, first-in-class molecule…

Original Article: Positive Phase III results for Lilly’s acute migraine drug candidate

NEXT ARTICLE

More From BioPortfolio on "Positive Phase III results for Lilly’s acute migraine drug candidate"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...